|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Xeloda (Capecitabine). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (525)
Cases resulting in a serious event (431)
Cases resulting in death (103)
Cases resulting in life threatening events (30)
Cases resulting in hospitalization (206)
Cases resulting in disability (21)
Cases resulting in other serious reactions (155)
Below is a sample of reports where side effects / adverse reactions may be related to Xeloda (Capecitabine). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 66 year old female receiving Xeloda (Capecitabine)
Reported by a physician from Portugal on 2007-10-31
Patient: 66 year old female
Adverse reactions / side effects: Arterial Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Xeloda (Capecitabine)
Adverse event in female receiving Xeloda (Capecitabine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-31
Patient: female, weighing 120.7 kg (265.5 pounds)
Adverse reactions / side effects: Abdominal Pain, Skin Exfoliation, Pyrexia, Fatigue, White Blood Cell Count Decreased, Vulvovaginal Mycotic Infection, Drooling, Vomiting, Nausea, Hypotension, Rhinitis, Palmar-Plantar Erythrodysaesthesia Syndrome, Hypoaesthesia, Tongue Coated, Fungal Infection, Diarrhoea, Lacrimation Increased, Onycholysis
Suspect drug(s):
Diflucan
Administration route: Oral
Indication: Prophylaxis
Start date: 2007-07-04
End date: 2007-07-09
Xeloda
Indication: Breast Cancer Metastatic
Taxotere
Indication: Breast Cancer Metastatic
Other drugs received by patient: Lasix; Neupogen
Adverse event in male receiving Xeloda (Capecitabine)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: male, weighing 69.0 kg (151.8 pounds)
Adverse reactions / side effects: Back Pain, Myalgia, Pain in Extremity, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Sutent
Administration route: Oral
Indication: Renal Cell Carcinoma Stage Unspecified
Xeloda
Administration route: Oral
Indication: Renal Cell Carcinoma Stage Unspecified
Start date: 2005-05-24
End date: 2005-06-19
Other drugs received by patient: Protonix; Zoloft; Colace; Vitamin B6; Mylanta; Mylanta; Magic Mouthwash; Cortef; Fludrocortisone Acetate
Adverse event in 57 year old female receiving Xeloda (Capecitabine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-30
Patient: 57 year old female
Adverse reactions / side effects: Abdominal Pain, Skin Exfoliation, Pain, Pyrexia, Fatigue, White Blood Cell Count Decreased, Vulvovaginal Mycotic Infection, Vomiting, Drooling, Nausea, Hypotension, Palmar-Plantar Erythrodysaesthesia Syndrome, Rhinitis, Hypoaesthesia, Rash, Tongue Coated, Fungal Infection, Diarrhoea, Onycholysis, Lacrimation Increased
Suspect drug(s):
Xeloda
Indication: Breast Cancer Metastatic
Start date: 2007-05-17
Xeloda
Diflucan
Administration route: Oral
Start date: 2007-07-05
Taxotere
Indication: Breast Cancer Metastatic
Start date: 2007-05-17
Other drugs received by patient: Lasix; Neupogen
Adverse event in 63 year old female receiving Xeloda (Capecitabine)
Reported by a physician from Greece on 2007-10-29
Patient: 63 year old female
Adverse reactions / side effects: Diplopia, Ill-Defined Disorder
Suspect drug(s):
Xeloda (Capecitabine)
Other drugs received by patient: Seropram; Primperan
Adverse event in male receiving Xeloda (Capecitabine)
Reported by a physician from United Kingdom on 2007-10-29
Patient: male
Adverse reactions / side effects: Haemolytic Anaemia
Suspect drug(s):
Avastin
Indication: Colorectal Cancer Metastatic
Xeloda
Indication: Colorectal Cancer Metastatic
Adverse event in female receiving Xeloda (Capecitabine)
Reported by a individual with unspecified qualification from United States on 2007-10-29
Patient: female, weighing 77.5 kg (170.5 pounds)
Adverse reactions / side effects: Nausea, Dehydration, Anorexia, Pyrexia, Neutrophil Count Decreased, Lethargy
Adverse event resulted in: hospitalization
Suspect drug(s):
Xeloda
Dosage: 24000 mg
Navelbine
Dosage: 47 mg
Herceptin
Dosage: 465 mg
Adverse event in 45 year old female receiving Xeloda (Capecitabine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-29
Patient: 45 year old female, weighing 89.2 kg (196.2 pounds)
Adverse reactions / side effects: Atelectasis, Back Pain, Cardiac Flutter, Lung Neoplasm, Chest Pain, Musculoskeletal Pain, Pleural Effusion
Suspect drug(s):
Xeloda (Capecitabine)
Other drugs received by patient: Atenolol; Zoloft; Prenatal Vitamins
Adverse event in 52 year old female receiving Xeloda (Capecitabine)
Reported by a physician from Japan on 2007-10-29
Patient: 52 year old female
Adverse reactions / side effects: Dialysis, Headache, Pyrexia, Eye Pain, Renal Failure Acute
Adverse event resulted in: death
Suspect drug(s):
Xeloda
Dosage: 3 weeks administration, followed by 1 week rest
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2007-05-08
End date: 2007-05-28
Xeloda
Dosage: 2 weeks administration, followed by 1 week rest
Administration route: Oral
Start date: 2007-06-12
End date: 2007-06-25
Navelbine
Dosage: generic name reported as vinorelbine ditartrate.
Indication: Breast Cancer Metastatic
Start date: 2007-06-12
End date: 2007-06-19
Navelbine
Start date: 2007-07-03
End date: 2007-07-03
Other drugs received by patient: Nolvadex; Methycobal; Methycobal; Methycobal; Methycobal; Methycobal; Indomethacin; Arimidex; Arimidex; Arimidex; Zometa; Loxonin; Loxonin; Aplace; Aplace; Flurbiprofen
Adverse event in 57 year old female receiving Xeloda (Capecitabine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-26
Patient: 57 year old female
Adverse reactions / side effects: Abdominal Pain, Skin Exfoliation, Drug Ineffective, Pain, Pyrexia, Fatigue, White Blood Cell Count Decreased, Vulvovaginal Mycotic Infection, Vomiting, Drooling, Nausea, Hypotension, Palmar-Plantar Erythrodysaesthesia Syndrome, Rhinitis, Rash, Hypoaesthesia, Tongue Coated, Diarrhoea, Fungal Infection, Lacrimation Increased, Onycholysis
Suspect drug(s):
Diflucan
Dosage: daily dose:100mg
Administration route: Oral
Indication: Prophylaxis
Taxotere
Dosage: daily dose:75mg/m2
Indication: Breast Cancer Metastatic
Xeloda
Dosage: daily dose:2500mg
Indication: Breast Cancer Metastatic
Other drugs received by patient: Lasix; Neupogen
Adverse event in 72 year old female receiving Xeloda (Capecitabine)
Reported by a pharmacist from Canada on 2007-10-26
Patient: 72 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Ear Discomfort, Deafness, Vertigo
Adverse event resulted in: disablity
Suspect drug(s):
Xeloda
Dosage: strengths: 150 mg and 500 mg; the patient received 1x150 mg and 2x500 mg tablets, twice daily
Administration route: Oral
Start date: 2007-01-08
End date: 2007-08-20
Xeloda
Administration route: Oral
Start date: 2007-09-01
Other drugs received by patient: Bisoprolol Fumarate; Lipitor; Monopril; Lozide; Haloperidol; Xanax; Senokot; Docusate Calcium
Adverse event in female receiving Xeloda (Capecitabine)
Reported by a physician from United Kingdom on 2007-10-26
Patient: female, weighing 169.8 kg (373.6 pounds)
Adverse reactions / side effects: Cardiac Failure, Pleural Effusion, Pulmonary Embolism
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Herceptin
Dosage: 460 mg, unk
Indication: Breast Cancer Metastatic
Start date: 2006-11-21
End date: 2007-08-22
Xeloda
Indication: Breast Cancer Metastatic
Start date: 2006-11-15
End date: 2007-08-15
Adverse event in male receiving Xeloda (Capecitabine)
Reported by a consumer/non-health professional from Germany on 2007-10-26
Patient: male
Adverse reactions / side effects: Death, Fatigue, Chromaturia, Asthenia
Adverse event resulted in: death
Suspect drug(s):
Xeloda (Capecitabine)
Adverse event in 36 year old male receiving Xeloda (Capecitabine)
Reported by a physician from United Kingdom on 2007-10-26
Patient: 36 year old male
Adverse reactions / side effects: Cardiac Arrest
Adverse event resulted in: death
Suspect drug(s):
Pazopanib
Administration route: Oral
Start date: 2007-08-06
End date: 2007-08-14
Xeloda
Administration route: Oral
Start date: 2007-08-06
End date: 2007-08-14
Oxaliplatin
Indication: Colorectal Cancer Metastatic
Start date: 2007-08-06
End date: 2007-08-06
Adverse event in 65 year old female receiving Xeloda (Capecitabine)
Reported by a physician from United Kingdom on 2007-10-26
Patient: 65 year old female
Adverse reactions / side effects: Mucosal Inflammation, Diarrhoea, Neutropenic Sepsis, Neutropenia
Adverse event resulted in: life threatening event
Suspect drug(s):
Xeloda (Capecitabine)
Other drugs received by patient: Tamoxifen Citrate
Adverse event in 67 year old female receiving Xeloda (Capecitabine)
Reported by a physician from Germany on 2007-10-26
Patient: 67 year old female
Adverse reactions / side effects: Cardiac Failure, Cardiovascular Insufficiency, Atrial Fibrillation, Arrhythmia
Suspect drug(s):
Xeloda (Capecitabine)
Adverse event in male receiving Xeloda (Capecitabine)
Reported by a physician from Germany on 2007-10-25
Patient: male
Adverse reactions / side effects: Haemolytic Anaemia
Suspect drug(s):
Xeloda
Avastin
Adverse event in male receiving Xeloda (Capecitabine)
Reported by a health professional (non-physician/pharmacist) from Switzerland on 2007-10-25
Patient: male
Adverse reactions / side effects: Diarrhoea, Sepsis, Hepatorenal Syndrome
Adverse event resulted in: death
Suspect drug(s):
Gemcitabine HCL
Dosage: 2000 mg
Start date: 2007-10-04
End date: 2007-10-04
Oxaliplatin
Dosage: 260 mg
Indication: Adenocarcinoma Pancreas
Start date: 2007-10-04
End date: 2007-10-04
Xeloda
Administration route: Oral
Start date: 2007-10-04
Other drugs received by patient: Lantus; Unknown Drug; Aspirin
Adverse event in 71 year old female receiving Xeloda (Capecitabine)
Reported by a consumer/non-health professional from United States on 2007-10-25
Patient: 71 year old female, weighing 59.9 kg (131.8 pounds)
Adverse reactions / side effects: Hypertensive Encephalopathy, Blood Pressure Increased, Gastrointestinal Toxicity, Sensation of Heaviness, Anaemia, Chills, Hypotension, Rash, Small Intestinal Obstruction, Vision Blurred, Gastrointestinal Oedema, Acute Prerenal Failure, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Xeloda
Administration route: Oral
Start date: 2007-02-08
End date: 2007-02-22
Xeloda
Administration route: Oral
Start date: 2007-02-23
End date: 2007-02-24
Antidiarrhoeal NOS
Start date: 2007-02-01
Contrast DYE
Cipro
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Altace; Atenolol
Adverse event in female receiving Xeloda (Capecitabine)
Reported by a physician from United States on 2007-10-25
Patient: female, weighing 97.5 kg (214.5 pounds)
Adverse reactions / side effects: Death
Adverse event resulted in: death
Suspect drug(s):
Xeloda (Capecitabine)
Adverse event in 83 year old female receiving Xeloda (Capecitabine)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: 83 year old female
Adverse reactions / side effects: Syncope, Diarrhoea, Nausea, Dehydration, Dizziness
Suspect drug(s):
Tykerb
Dosage: 5tab per day
Indication: Drug USE FOR Unknown Indication
Start date: 2007-10-06
Xeloda
Dosage: 6tab per day
Indication: Drug USE FOR Unknown Indication
Start date: 2007-10-06
Adverse event in male receiving Xeloda (Capecitabine)
Reported by a consumer/non-health professional from Germany on 2007-10-24
Patient: male
Adverse reactions / side effects: Death, Fatigue, Chromaturia, Asthenia
Adverse event resulted in: death
Suspect drug(s):
Xeloda (Capecitabine)
Adverse event in 70 year old female receiving Xeloda (Capecitabine)
Reported by a consumer/non-health professional from United States on 2007-10-23
Patient: 70 year old female
Adverse reactions / side effects: Oral Intake Reduced, Burning Sensation, Diarrhoea
Adverse event resulted in: death
Suspect drug(s):
Xeloda (Capecitabine)
Adverse event in male receiving Xeloda (Capecitabine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-23
Patient: male
Adverse reactions / side effects: Pneumothorax, Chronic Obstructive Pulmonary Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Oxaliplatin
Dosage: 170 mg d1+15 q 28 days iv drip
Indication: Gastric Cancer
Start date: 2007-04-12
End date: 2007-10-04
Xeloda
Dosage: 1500 mg d1-7+15-21 q28 day po
Administration route: Oral
Indication: Gastric Cancer
Start date: 2007-04-12
End date: 2007-09-03
Adverse event in 57 year old female receiving Xeloda (Capecitabine)
Reported by a individual with unspecified qualification on 2007-10-22
Patient: 57 year old female
Adverse reactions / side effects: Abdominal Pain, Skin Exfoliation, Pain, Pyrexia, Fatigue, White Blood Cell Count Decreased, Vulvovaginal Mycotic Infection, Vomiting, Drooling, Nausea, Hypotension, Palmar-Plantar Erythrodysaesthesia Syndrome, Rhinitis, Rash, Tongue Coated, Fungal Infection, Diarrhoea, Hypoaesthesia Eye, Onycholysis, Lacrimation Increased
Suspect drug(s):
Taxotere
Indication: Breast Cancer Metastatic
Start date: 2007-05-17
Diflucan
Administration route: Oral
Indication: Prophylaxis
Start date: 2007-07-04
Xeloda
Indication: Breast Cancer Metastatic
Start date: 2007-05-17
Xeloda
Dosage: dose: 4 tablets twice daily for 7 days
Administration route: Oral
Other drugs received by patient: Lasix; Neupogen
|
